Ccl22 - chemokine (C-C motif) ligand 22 Gene

Also Known as MDC; DCBCK; ABCD-1; Scya22

Species: Mus musculus

Gene Type: protein coding
Gene ID: 20299

Summary

Predicted to enable CCR Chemokine Receptor binding activity and chemokine activity. Predicted to be involved in several processes, including cellular response to cytokine stimulus; leukocyte chemotaxis; and positive regulation of ERK1 and ERK2 cascade. Predicted to act upstream of or within chemotaxis. Located in extracellular space. Is expressed in inguinal lymph node; thymus; and thymus primordium. Orthologous to human CCL22 (C-C motif chemokine ligand 22). [provided by Alliance of Genome Resources, Apr 2022]

Ccl22 Products (1)

mRNA Protein Name
NM_009137.2 NP_033163.1 C-C motif chemokine 22 precursor

Gene Ontology

  • Cellular Component
Cellular Component GO Annotation Evidence References Source
located in extracellular space IDA
IDA: Inferred from direct assay
23460747 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

C-C motif chemokine 22

  • CC chemokine ABCD-1

  • SMALL INDUCIBLE CYTOKINE A22 PRECURSOR (CC CHEMOKINE ABCD-1) (ACTIVATED B AND DENDRITIC CELL-DERIVED)

  • activated B and dendritic cell-derived

  • dendritic cell and B cell derived chemokine

  • small inducible cytokine subfamily A, member 2

Recombinant Ccl22 Proteins

Cat. No. Product Name Accession Purity
HY-P7248 MDC/CCL22 Protein, Mouse (His, solution) O88430 (G25-S92) ≥ 90%, as determined by reducing SDS-PAGE.

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-148494 Tivumecirnon Antagonist 99.48% Phase 2

Pre-clinical Phase

Bioactive Molecules (7)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-103364A C-021 dihydrochloride Antagonist 99.73% Unkown
HY-103364 C-021 Inhibitor 99.95% Unkown
HY-182564 ST45177901 Antagonist / Unkown
HY-RS02092 CCL22 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-174760 Human CCL22 mRNA / Unkown
HY-RS16703 Ccl22 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23137 Ccl22 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P992378 HZ-1127 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Ccl22 NCBI NCBI:6367